JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma.
about
Novel endogenous angiogenesis inhibitors and their therapeutic potentialJWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.JWA loss promotes cell migration and cytoskeletal rearrangement by affecting HER2 expression and identifies a high-risk subgroup of HER2-positive gastric carcinoma patients.Combination curcumin and (-)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway.Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma.JWA suppresses the invasion of human breast carcinoma cells by downregulating the expression of CXCR4.
P2860
JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
JWA inhibits melanoma angiogen ...... nostic biomarker for melanoma.
@en
JWA inhibits melanoma angiogen ...... nostic biomarker for melanoma.
@nl
type
label
JWA inhibits melanoma angiogen ...... nostic biomarker for melanoma.
@en
JWA inhibits melanoma angiogen ...... nostic biomarker for melanoma.
@nl
prefLabel
JWA inhibits melanoma angiogen ...... nostic biomarker for melanoma.
@en
JWA inhibits melanoma angiogen ...... nostic biomarker for melanoma.
@nl
P2093
P356
P1433
P1476
JWA inhibits melanoma angiogen ...... nostic biomarker for melanoma.
@en
P2093
Guohong Zhang
Jianwei Zhou
Magdalena Martinka
Maham Farshidpour
Yabin Cheng
P304
P356
10.1093/CARCIN/BGT318
P407
P577
2013-09-24T00:00:00Z